Silynxcom CFO discloses initial option holdings

Silynxcom Ltd. Chief Financial Officer Ilan Akselrod filed an initial ownership statement showing existing stock option holdings.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Silynxcom Ltd. Chief Financial Officer Ilan Akselrod filed an initial ownership statement showing existing stock option holdings. He holds fully vested share options to acquire 369 ordinary shares at an exercise price of $6.0100, 20,868 shares at $1.2700, and 75,883 shares at $1.3700, with expiration dates in 2028.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Akselrod Ilan

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Share options (right to buy)	--	--	--
holding	Share options (right to buy)	--	--	--
holding	Share options (right to buy)	--	--	--

Holdings After Transaction: Share options (right to buy) — 97,120 contracts (Direct)

Footnotes (3)

F1. The options were granted on March 18, 2018 and became fully vested as of March 18, 2020.
F2. The options were granted on March 18, 2018 and became fully vested as of March 18, 2021.
F3. The options were granted on January 1, 2023 and became fully vested as of January 1, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Silynxcom (SYNX) Form 3 filing by CFO Ilan Akselrod show?

The Form 3 shows CFO Ilan Akselrod’s existing stock option holdings in Silynxcom. It lists fully vested options over 369, 20,868, and 75,883 ordinary shares at specified exercise prices, all expiring in 2028, establishing his initial reported equity position.

How many Silynxcom (SYNX) shares can the CFO acquire under his reported options?

The CFO can acquire 369, 20,868, and 75,883 Silynxcom ordinary shares through three option grants. Each grant is fully vested, giving him the right to exercise for those numbers of shares at fixed exercise prices before the options expire in 2028.

What are the exercise prices of the Silynxcom (SYNX) options reported by the CFO?

The reported options have exercise prices of $6.0100, $1.2700, and $1.3700 per Silynxcom ordinary share. These fixed prices determine the cost to acquire shares if he chooses to exercise the fully vested options before their 2028 expiration dates.

Are the Silynxcom (SYNX) CFO’s stock options already vested according to the Form 3?

Yes, all reported options are fully vested. Footnotes state the 2018 grants vested by March 18, 2020 and March 18, 2021, and the 2023 grant vested by January 1, 2026, meaning the CFO can exercise them at any time before expiration.

When do the Silynxcom (SYNX) CFO’s reported stock options expire?

The options with exercise prices of $6.0100 and $1.2700 expire on March 18, 2028, while the options at $1.3700 expire on January 1, 2028. After these dates, the rights to buy the underlying shares lapse if unexercised.

Does the Silynxcom (SYNX) Form 3 indicate recent buying or selling by the CFO?

No, the Form 3 reflects holdings, not recent trades. It lists existing, fully vested stock options and their terms but shows no buy or sell transactions. The filing establishes the CFO’s derivative equity position as he becomes a reportable insider.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/19/2026 - 06:35 AM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Akselrod Ilan

(Last)

(First)

(Middle)

7 GIBOREI ISRAEL

(Street)

NETANYA

4250407

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Silynxcom Ltd. [ SYNX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Share options (right to buy)⁽¹⁾	03/18/2018	03/18/2028	Ordinary Shares, no par value per share	369	$6.01	D
Share options (right to buy)⁽²⁾	03/18/2018	03/18/2028	Ordinary Shares, no par value per share	20,868	$1.27	D
Share options (right to buy)⁽³⁾	01/01/2023	01/01/2028	Ordinary Shares, no par value per share	75,883	$1.37	D

Explanation of Responses:

1. The options were granted on March 18, 2018 and became fully vested as of March 18, 2020.

2. The options were granted on March 18, 2018 and became fully vested as of March 18, 2021.

3. The options were granted on January 1, 2023 and became fully vested as of January 1, 2026.

	/s/ Ilan Akselrod	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR